Justin M Balko

51PUBLICATIONS
294CO-AUTHORS
Tumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jun 03, 2026
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

|Apr 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

|Jan 07, 2026
CXCR6<sup>+</sup> T Cells Drive Immune Checkpoint Inhibitor Myocarditis.

Amir Z Munir, Alan Gutierrez, Cade J Krawiec

|Dec 10, 2025
Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance.

Ann Hanna, Xiaopeng Sun, Quanhu Sheng

|Nov 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial.

Adrienne G Waks, Jingxin Fu, Xiangying Chu

|Oct 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.

Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann

Pageof 9

Frequent Collaborators

17 joint publications

Paula I Gonzalez-Ericsson

9 joint publications

Xiaopeng Sun

7 joint publications

Melinda Sanders

7 joint publications

Douglas B Johnson